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Background: Substance use disorders (SUDs) contribute significantly to global rates of morbidity and mortality.
Internet- and mobile-based interventions (IMIs) have been suggested as an adjunct to face-to-face health services.
However, the evidence for the cost-effectiveness of IMIs for SUDs is scant. Methods: A comprehensive literature
search in PubMed, PsycINFO, the Cochrane Central Register of Controlled Trials, NHS Economic Evaluations
Database, NHS Health Technology Assessment Database, Office of Health Economics Evaluations Database and
EconLit was conducted. We included economic evaluations alongside randomized controlled trials of IMIs for SUDs
compared with a control group. Results: Of 1687 abstracts identified, 11 studies met the inclusion criteria.
Targeted conditions were alcohol use disorder (four studies) and tobacco smoking (five studies) whereas two
studies included any SUD. Cost-effectiveness results demonstrated that IMIs had a firm probability of being
more cost-effective than TAU (e.g. less costs per additional abstinent person). Compared with (online) psycho-
education, evidence towards an additional benefit of IMIs was less clear. Regarding cost-utility (e.g. costs per
quality-adjusted life year gained), except for one study, results suggested that TAU and online psycho-education
would probably be more preferable than IMIs. Quality of study reporting was at least adequate. Conclusions: The
likelihood of IMIs being more cost-effective than TAU looks promising but more economic evaluations are needed
in order to determine the economic merit of IMIs. With an increasing pressure on health care budgets, strategies
to disseminate effective interventions at affordable costs are required. This review suggests that IMIs might carry
that promise and have potential as a cost-effective strategy to scale-up existing evidence-based treatments for
SUDs.
Systematic review registration: The systematic review has been registered in the PROSPERO database (no.
CRD42018099486).
. .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . .
Introduction
Substance use disorders (SUDs) including tobacco and alcoholcontribute significantly to global rates of morbidity and
mortality.1 Estimated 12-month prevalence of alcohol use disorder
range from 11.8% in European regions2 to 12.7% in the US
population.3 The hazardous and harmful use of alcohol is a global
problem, contributing 4.6% of the total global burden of disease,
with the highest rates reported in the European and American
regions (17.3% and 14.2%, respectively).4 In 2014, overall
prevalence rates of tobacco smoking were estimated at 27.2% in
Europe.5 Tobacco smoking is a major preventable cause of death
in both developed and developing countries.6 Smoking imposes a
huge economic burden on society—currently up to 15% of the total
healthcare costs in developed countries.7
There is robust evidence for the effectiveness of brief, face-to-face
interventions in helping people to quit smoking8 and psychosocial
treatments for substance abuse and dependence.9 In Europe,
however, only 22.3% of alcohol dependent individuals seek profes-
sional treatment.10 Numerous impediments restrict the accessibility
of available treatments, including costs, transport, inconvenience,
fear of social- and work-related stigma and discrimination.11
Internet- and mobile-based interventions (IMIs) have been
suggested to overcome many of these barriers to accessing
traditional health services. In particular, IMIs can be anonymous
and accessed whenever required, two factors that are especially
relevant for SUDs.12 In addition, IMIs have demonstrated effective-
ness for harmful alcohol use13 and smoking cessation.6,8 For harmful
alcohol use, meta-analytic evidence showed a small but significant
overall effect size in favour of IMIs compared with control
conditions (g = 0.20, 95% CI: 0.13–0.27, P< .001).13 Recent meta-
analytic evidence revealed an effect in favour of IMIs compared with
non-active controls for smoking cessation (RR: 1.15, 95% CI: 1.01–
1.30).8
Although the initial costs of designing, building and testing IMIs
can be quite high, the low marginal costs of providing IMIs to
additional users are believed to result in lower overall expend-
itures.14 In addition, IMIs are likely to reduce health service
delivery costs compared with conventional face-to-face therapy, as
they generally involve minimal or no contact with mental health
professionals and reduce travel costs. IMIs are therefore assumed
to be cost-effective, but it is unclear how strong this evidence is,
and what the quality of this evidence is. This information is,
however, critical for policymakers to allocate scarce health care
resources.
Previous reviews on the economic evidence of IMIs, however,
have focussed solely on physical illnesses,15 mood and anxiety
disorders16,17 or IMIs based on cognitive behaviour therapy.18 The
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only systematic review on evidence-based IMIs for mental health
problems and disorders (including harmful alcohol use and
smoking cessation) consists of studies published up to 2014.
However, more economic evaluations of IMIs for SUDs have been
conducted in recent years. We therefore aimed to systematically
review the available literature on trial-based economic evaluations
of IMIs for SUDs in all age groups compared with control
conditions.
Methods
The current review was conducted in agreement with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA).19 The protocol of this review is registered in the
International Prospective Register of Systematic Reviews
(PROSPERO; registration number CRD42018099486).
Search strategy
Eligible cost-effectiveness studies were identified through a
(PubMed) search in Medline, PsycINFO, Cochrane Central
Register of Controlled Trials, NHS Economic Evaluations Database
(NHSEED), NHS Health Technology Assessment (NHS HTA) and
EconLit for articles published until 31 May 2018. Search terms
indicative for SUDs, economic evaluations and IMIs were used
(see Supplemental Data for full search string). References lists of
previous systematic reviews and eligible studies were also
examined to identify papers missed by database searches.
Inclusion and exclusion criteria
Randomized controlled trials were included if they were comparative
economic evaluations (e.g. cost-effectiveness and cost-utility
analyses) of IMIs for the prevention or treatment of SUDs in all
age groups published in English, German or Dutch. IMIs were
defined as psychological interventions that were provided in an
online setting, defined as internet-, online-, web- or mobile-based
(with human support/guided or as a self-help intervention/
unguided). Guidance usually consists of written non-therapeutic
feedback by an e-Coach after a completed intervention module.
The main purpose of the guidance is to encourage the participant
to work through the self-help material independently. Studies were
excluded if the IMI was offered as blended care, i.e. the combination
of internet- and face-to-face treatment modalities.20 No exclusion
criteria for comparator conditions were defined. Only full economic
evaluations that reported comparisons of costs (including costs of
interventions with or without costs beyond of the intervention) and
outcomes of at least two alternatives were included. Cost-of-illness
studies and descriptive economic studies only reporting costs
without comparative outcomes or reporting costs and outcomes of
only one intervention were excluded. Model-based economic evalu-
ations were also excluded due to methodological differences
compared with trial-based economic evaluations possibly biasing
internal validity of the review. Conference abstracts, protocol
papers, case studies, non-peer-reviewed articles and articles in
languages other than English, German or Dutch, pilot studies, feasi-
bility studies, cohort, observational and cross-sectional studies were
excluded.
Study selection and extraction
The first author (C.B.) completed the literature search. Two inde-
pendent reviewers (C.B. and F.K.) screened abstracts for inclusion of
the publications in the review and when the abstract did not provide
sufficient information to determine eligibility the full text was read.
Any disagreement between C.B. and F.K. was resolved by discussion,
while a third reviewer (D.D.E.) was consulted if C.B. and F.K. could
not reach consensus. Included studies were classified as cost-effect-
iveness or cost-utility studies for the prevention or treatment of
identified SUD conditions. A narrative review of the characteristics
of included studies was done. Information to be extracted included
SUD condition; study sample; intervention; comparator (e.g.
treatment as usual, face-to-face treatment); outcome measurement
and incremental cost-effectiveness ratio (ICER) results; the type of
cost-effectiveness study performed (including cost-effectiveness
analysis [CEA, where outcomes are expressed in clinical units,
such as clinical scales] and cost-utility analysis [CUA, where
outcomes are presented in generic units such as quality-adjusted
life years (QALYs)]; study perspective (e.g. societal, health care,
provider) and time horizon. To compare costs or ICERs across all
studies, all costs were converted into Euro. First, by using country-
specific gross domestic product inflators the currency of the study
was converted into 2014 equivalent (e.g. the average year of included
studies). Second, purchasing power parities (PPPs) were used to
convert to Euro (e.g. Euro area, 19 countries) for the studies,
which reported the costs in non-Euro currencies.21 According to
the National Institute for Health and Clinical Excellence [NICE] a
willingness-to-pay (WTP) ceiling of £20 000–£30 000 should be
applied for gaining one QALY. This WTP ceiling range corresponds
with E24 600–E36 900 (PPP converted and indexed for the reference
year 2014) and were used in our review to aid interpretation of the
results.
Quality assessment
The quality of included studies were assessed by the 24-item
Checklist of the Consolidated Health Economic Evaluation
Reporting Standards (CHEERS).22 Quality assessment were
completed for each included study by C.B. and reviewed by F.K.
In case of disagreement a third reviewer (D.D.E.) was consulted. A
scoring system to classify study quality was used where a point was
given for each criterion met. A point was withheld where criteria
were not fulfilled completely. A score of quality assessment was given
based on the percentage of criteria met by each study that ranged
from 0% to 100%. To report on quality of reporting, four categories
were used: excellent (100%), good (75—99%), average (50—74%)
and poor (< 50%) quality of reporting. In addition, we assessed the
quality of included studies using the Cochrane Collaboration’s tool
for assessing risk of bias. Results can be found in the Supplementary
Data.
Results
Study selection
The literature search identified 1687 articles. After removal of
duplicates, a total of 1598 abstracts were screened and 156 full text
articles were retrieved for further consideration. Of those, 11 studies
met inclusion criteria including 14 comparisons (see figure 1). In the
excluded studies, for which full text were retrieved, 83 studies did
not evaluate an IMI (i.e. booklets/letters were sent by post), in 2
studies the IMI was offered as blended care, 34 studies did not meet
criteria for a full economic evaluation (i.e. costs were examined but
not in relation to the clinical outcome), 3 studies were meta-analyses
or systematic reviews, 12 studies evaluated economic effects with a
decision-analytical model, 8 studies reported on the design of an
economic evaluation and 3 studies did not evaluate an IMI for
SUDs.
Characteristics of included studies
A description of included studies is provided in table 1. Four of the
11 studies were conducted in The Netherlands, 4 in the USA, 1 study
in Denmark, 1 in the United Kingdom and another in Italy. All
studies targeted adults, except one, which was directed at adoles-
cents.23 A total of 18 652 participants were included across the
included studies. Target conditions were alcohol use disorder
(four studies) and tobacco smoking (five studies) whereas two
2 European Journal of Public Health
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studies included any SUD. Types of economic evaluations included
cost-effectiveness (nine studies) and cost-utility analyses (seven
studies), which were performed from a societal (four studies),
provider (four studies), health care (four studies) or payer’s (two
studies) perspective. Most of the interventions were based on
theories of motivational and behaviour change or cognitive behav-
ioural therapy. Comparators included treatment as usual (TAU)
(four studies), (online) psycho-education (four studies), face-to-
face treatment (two studies) and an IMI with a different guidance
format compared with the IMI under study (one study). We refer to
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Figure 1 PRISMA flow diagram
Table 1 Main characteristics of included studies
Author Country Target condition Sample Sample size Type of study Study perspective Time horizon
Blankers et al.24 Netherlands Alcohol use disorder Adults 136 CEA Societal 6months
CUA Health care
Drost et al.23 Netherlands Alcohol use disorder Adolescents 2493 CEA Societal 4months
Health care
Hunter et al.25 Italy Alcohol use disorder Adults 763 CUA Italian NHS 12months
NHS
Wallace et al.26 UK Alcohol use disorder Adults 7935 CUA Not clear Not clear
Calhoun et al.27 USA Smoking Veterans 413 CEA Payer 12months
CUA
Graham et al.28 USA Smoking Adults 2005 CEA Payer 18months
Skov-Ettrup et al.29 Denmark Smoking Adults 1810 CEA Not clear 12months
Smit et al.30 Netherlands Smoking Adults 414 CEA Societal 12months
CUA
Stanczyk et al.31 Netherlands Smoking Adults 2099 CEA Societal 12months
CUA
Murphy et al.32 USA Any SUD Adults 507 CEA Provider 12weeks
CUA
Olmstead et al.33 USA Any SUD Adults 77 CEA Provider 8weeks
Notes: CEA, cost-effectiveness analysis; CUA, cost-utility analysis; NHS, National Health Service; SUD, substance use disorder.
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TAU when a comparator condition was either explicitly mentioned
as TAU in the published papers or represented standard care/current
best practice according to available treatment guidelines.
Findings of included studies
Characteristics of and results for economic evaluations of IMIs for
SUDs can be found in table 2. Table 2 represents the actual costs that
were published in the specific papers whereas costs presented
throughout the paper are stated in standardized metrics (Euros) to
compare costs across the published studies.
Alcohol use disorder
Two of the four studies in IMIs for alcohol use disorder conducted a
CEA, from both the societal and the Dutch health care perspec-
tive.23,24 Three of the four studies performed a CUA,24–26 with one
study applying both a societal and health care perspective,24 one
study deploying a health care perspective25 and one study not
clearly stating the study perspective.26
Cost-effectiveness analysis
 Blankers et al.24 took the Dutch health care perspective as well as
the societal perspective to evaluate the economic benefit of a
guided IMI compared with an unguided IMI in adults
concluding that the guided IMI based on CBT and motivational
interviewing techniques offered good value for money compared
with the unguided IMI within a 6-month time horizon. From the
societal perspective (Dutch health care perspective), the reported
median ICER was E3817 (E1254) per additional treatment
responder concluding that above a WTP of approximately
E4000 (E1300) per additional responder, the guided IMI is
considered cost-effective compared with the unguided IMI. For
the ICERs expressed in local currency units (see table 2).
 Drost et al.23 showed that an unguided IMI with computer-
tailored feedback based on theories of motivational and
behaviour change could be a cost-effective way of targeting prob-
lematic alcohol use and binge drinking among adolescents. From
the societal perspective (Dutch health care perspective), the
ICER/reduction of one glass of alcohol per week was E62
(E40) and E144 (E79) for one binge drinking occasion per
30 days. With increasing WTPs (up to E500), the probability
of the IMI being cost-effective increased to approximately 80%
for both outcomes from both perspectives.
Cost-utility analysis
 From the societal perspective, Blankers et al.24 found that the
guided IMI resulted in better health effects. An additional
QALY was gained at a median incremental cost of E15 948. At
a WTP of E21 683/QALY gained, the probability that the guided
IMI was considered to be more cost-effective than the unguided
IMI was 60%. From the Dutch health care perspective, the
median ICER was E5088/QALY gained.
Two studies evaluated the cost-effectiveness of an unguided inter-
active IMI based on theories of motivational and behaviour change
and CBT.25,26
 Hunter et al.25 in their Italian study observed that referral of
patients to an unguided interactive IMI compared with referral
to a brief face-to-face intervention delivered by the General
Practitioner (GP; TAU) was associated with additional benefits
at 12-month follow-up. From the perspective of the Italian NHS,
the IMI had a probability of 84% of being cost-effective at a WTP
of E25 000/QALY gained. Applying English NHS costs, this
probability was 75% at a WTP of E31 000/QALY gained.
 In contrast, Wallace et al.26 could not find support for the
hypothesis that the unguided interactive IMI offered additional
benefit over online psycho-education in terms of clinical effect-
iveness, with incremental costs being slightly in favour of online
psycho-education. However, in this study neither the study per-
spective nor the time horizon was clear.
In general, findings of the two cost-effectiveness analyses
suggested that IMIs for alcohol use disorder provide good value
for money. Cost-utility analyses supported these findings.
Reported ICERs per QALY gained were all below (or within) the
WTP range of E24 600–E36 900. Probabilities that IMIs were cost-
effective ranged from 60% to 84% with higher probabilities when a
public health care perspective was taken compared with the societal
perspective.
Tobacco smoking
All five studies in IMIs for smoking cessation employed a CEA with
incremental costs per quitter with at least a 12-month time
horizon,27–31 with one study having a prolonged follow-up of
18 months.28 Two studies performed the CEA from the payer’s per-
spective,27,28 two studies from the societal perspective,30,31 and in
one study the perspective was not clear.29 Three studies additionally
evaluated incremental costs per QALY gained, from either the
payer’s perspective27 or the societal perspective.30,31
Cost-effectiveness analysis
 Skov-Ettrup et al.29 showed an ICER of E25/additional quitter
when comparing an unguided IMI to a self-help booklet.
However, the study perspective was unclear and incremental dif-
ferences in effectiveness were not statistically significant.
Two studies investigated the cost-effectiveness of an unguided IMI
from the payer’s perspective:
 Calhoun et al.27 did not find statistically significant differences in
incremental abstinence rates between the IMI paired with a tele-
medicine clinic for nicotine replacement therapy and an assisted
referral to speciality smoking cessation clinic-based care, thus no
ICER was calculated.
 Graham et al.28 found that the unguided IMI was dominated by
online psycho-education. Enhancing the IMI with telephone
counselling resulted in higher costs but also greater effects,
thus the enhanced IMI was considered a cost-effective
approach to smoking cessation compared with the IMI alone
with an ICER of E2897/additional quitter.
Two studies evaluated various versions of an unguided IMI with
computer-tailored feedback from the societal perspective.30,31
 In the first study by Smit et al.,30 an unguided IMI coupled with
computer-tailored feedback or face-to-face counselling by a
practice nurse, respectively, was compared with TAU. The
study revealed that the IMI with computer-tailored feedback
would probably be the most cost-effective treatment option
when incremental costs per additional quitter were evaluated
(i.e. 78% at a WTP of E19 038). In contrast to Graham et
al.,28 Smit et al.30 found that the IMI dominated the combination
of IMI and face-to-face counselling meaning that the IMI
generated larger health effects at lower costs compared with the
employment of a nurse to provide feedback. Compared with
TAU, the ICER for the IMI was E5394/additional quitter.30
However, although Smit et al.30 stated that they employed a
societal perspective; they did not include indirect costs.
 The second study by Stanczyk et al.31 found that at a WTP of
E18 058/quitter, an unguided IMI with video-based computer-
tailored feedback was the most cost-effective treatment
option for smoking cessation (i.e. 70%) compared with text-
based computer-tailored feedback (i.e. 11%) and online
4 European Journal of Public Health
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psycho-education (i.e. 20%). The ICER for the IMI with video-
based feedback compared with online psycho-education was
E1505/additional quitter and E50 561/additional quitter for
the IMI with text-based feedback compared with online
psycho-education.
Cost-utility analysis
 As in the CEA, Calhoun et al.27 did not find statistically signifi-
cant differences in incremental effectiveness (i.e. QALY gained)
between the IMI paired with a tele-medicine clinic for nicotine
replacement therapy and an assisted referral to speciality
smoking cessation clinic-based care from the payer’s perspective,
thus no ICER was calculated.
 Smit et al.30 showed in cost-utility analyses from the societal
perspective that TAU would probably be the most preferable
treatment option with a probability of 64% at a WTP of
E19 038/QALY gained. The IMI alone was dominated by TAU
and the ICER for the nurse-led feedback compared with TAU
was E42 625/QALY gained. Thus, at a WTP of approximately
E43 000, TAU and the IMI coupled with counselling would be
equally preferable.
 Stanczyk et al.31 revealed in cost-utility analyses that from the
societal perspective at a WTP of E18 058, online psycho-
education seemed to be the most preferable treatment choice
(i.e. 43%), followed by the IMI with video-based feedback (i.e.
39%) and the IMI with text-based feedback (i.e. 18%).
Compared with online psycho-education, the ICER for the IMI
with video-based feedback was E60 192/QALY gained whereas
the IMI with text-based feedback was dominated by both the
IMI with video-based feedback and online psycho-education.
In general, results from cost-effectiveness studies conducted from
the payer’s perspective did not suggest an economic merit of IMIs.
Findings from cost-effectiveness analyses employing a societal per-
spective suggested that IMIs for smoking cessation have an
acceptable likelihood of being cost-effective compared with either
TAU or online psycho-education with probabilities ranging from
70% to 78%. Cost-utility analyses, however, did not support the
hypothesis that IMIs are cost-effective as reported ICERs were well
above the acceptable cost-effectiveness threshold of E24 600–
E36 900.
Any SUD
Two studies evaluated IMIs from a provider’s perspective with a
post-treatment time horizon that were targeted to patients
suffering from any SUD (i.e. stimulants, opioids, alcohol and
marijuana).
 Murphy et al.32 found an ICER of a Therapeutic Education
System (TES) including an internet-based reinforcement
approach and computer-assisted contingency management as
an adjunct to TAU compared with TAU alone of E6745/
abstinent year. At a WTP of E14 869, the probability of TES
plus TAU to be considered cost-effective was 95%. Cost-utility
analyses revealed that TAU dominated TES plus TAU.
Table 3 Quality assessment with CHEERS checklist
CHEERS statement checklist Blankers
et al.24
Calhoun
et al.27
Drost
et al.23
Graham
et al.28
Hunter
et al.25
Murphy
et al.32
Olmstead
et al.33
Skov-Ettrup
et al.29
Smit
et al.30
Stanczyk
et al.31
Wallace
et al.26
Title and abstract
Title 1 0 1 1 1 1 1 0 1 1 0
Abstract 1 0 1 1 1 1 1 0 1 1 0
Introduction
Background and objectives 1 1 1 1 1 1 1 1 1 1 1
Methods
Target population and subgroups 1 1 1 1 1 1 1 1 1 1 1
Setting and location 1 1 1 1 1 1 1 1 1 1 0
Study perspective 1 1 1 1 1 1 1 1 1 1 0
Comparators 1 1 1 1 1 1 1 1 1 1 1
Time horizon 1 1 1 1 1 1 1 1 1 1 0
Discount rate 0 0 0 1 1 0 0 0 1 1 0
Choice of health outcomes 1 1 1 1 1 1 1 1 1 1 1
Measurement of effectiveness 1 1 1 1 1 1 1 1 1 1 1
Measurement and valuation of
preference based outcomes
1 0 N/A 0 1 0 N/A N/A 0 1 1
Estimating resources and costs 1 1 1 1 1 1 1 1 1 1 1
Currency, price data and
conversion
1 0 1 0 1 1 0 1 1 1 1
Choice of model N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Assumptions N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Analytical methods 1 0 1 0 1 1 1 0 1 1 0
Results 0
Study parameters 1 0 1 1 1 1 0 0 0 0 1
Incremental costs and outcomes 1 1 1 1 1 1 1 1 1 1 1
Characterizing uncertainty 1 0 1 0 1 1 1 0 1 1 0
Characterizing heterogeneity N/A N/A 1 1 N/A N/A N/A 0 N/A N/A 0
Discussion
Study findings, limitations, gener-
alizability and current knowledge
1 1 1 1 1 1 1 1 1 1 1
Other
Source of funding 1 1 1 1 1 0 0 1 1 1 1
Conflicts of interest 1 1 1 1 1 1 0 1 1 1 1
CHEERS score 20/21 13/21 20/21 18/22 21/21 18/21 16/21 13/21 19/21 19/21 14/22
Quality of reporting 95%
good
62%
average
95%
good
82%
good
100%
excellent
86%
good
76%
good
62%
average
90%
good
90%
good
64%
average
Notes: CHEERS, Checklist of the Consolidated Health Economic Evaluation Reporting Standards; N/A, the item is not applicable.
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 Olmstead et al.33 showed that an unguided IMI based on CBT
plus TAU appeared to be good value for money compared with
TAU alone. The ICER was E1340/drug-free specimen, with a
probability that the IMI plus TAU was more cost-effective than
TAU of 14% at a WTP of E0 and 90% at a WTP of E4786.
Cost-effectiveness analyses on IMIs targeting any SUD showed
that IMIs could provide good value for money from a provider’s
perspective within a short time horizon when a provider is willing to
pay E5000–E15 000 for a drug-free specimen or abstinent year, re-
spectively. As for alcohol use disorder and tobacco smoking, findings
of the CUA did not support the hypothesis that IMIs are a more
cost-effective than TAU.
Quality assessment
All of the studies included in this review met over 50% of quality
criteria indicating that the quality of reporting was at least of average
quality (see table 3). The mean percentage of items met in the
studies was 82%. One study was classified as ‘excellent’.25 Seven
studies fulfilled criteria of good quality of reporting.23,24,28,30–33
Common reasons why these studies did not achieve 100% of the
criteria were a lack of reporting the choice of discount rate, infor-
mation on valuation of preference-based outcomes and reporting of
parameters required to calculate overall costs and consequences and
their associated values. Three studies were only classified as average
quality of reporting with the lowest value of 62% of met
criteria.26,27,29 Common criteria that were not met included the de-
scription of analytical methods and characterization of uncertainty.
Discussion
Summary of main findings
The aim of this review was to provide an overview of trial-based
health-economic evaluation studies of IMIs for SUD compared with
control conditions. Findings of cost-effectiveness analyses suggested
that IMIs for SUDs compared with TAU provide good value for
money. One of the two studies comparing an IMI to a face-to-face
treatment found an acceptable likelihood of the IMI to be cost-
effective25 whereas the other study did not find significant differ-
ences in the clinical outcome.27 Compared with (online) psycho-
education, evidence for an additional benefit of IMIs is less clear,
as only one of four studies showed that an IMI had a higher prob-
ability of being more cost-effective than psycho-education.
Regarding cost-utility (i.e. incremental costs per QALY gained),
except for one study,25 results suggested that TAU and online
psycho-education would probably be more preferable than IMIs.
One study provided supporting evidence that a guided IMI offers
better value for money than unguided self-help, both in cost-effect-
iveness and cost-utility analyses.24 Due to the heterogeneity in types
of IMIs, sorts of ‘treatment-as-usual’ and targeted SUD populations,
no single and general conclusion about the cost-effectiveness of IMIs
can be presented in this fragmented research field.
Quality of included studies
Some methodological limitations need to be mentioned. Many
studies provided insufficient information on parameters required
to calculate overall costs and consequences and their associated
values. Of the 11 studies included in the review, six did not report
on these parameters27,29–31,33 thereby hindering transparent inter-
pretation of their evaluation. Furthermore, the analytical methods
including handling sampling uncertainty were not clearly reported
and justified in four studies.26–29 Presenting cost-effectiveness planes
and cost-effectiveness acceptability curves may be appropriate ways
to present stochastic uncertainty due to sample error, but those
graphs were not always produced in the reviewed studies. In
addition, one of the studies that adopted a societal perspective did
not include productivity costs in the analyses.30
Comparison with prior research
The current review found that the number of economic evaluations
alongside randomized controlled trials of IMIs for SUDs has signifi-
cantly increased since 2014. Findings from our systematic review
support findings from previous reviews that IMIs could be a cost-
effective way to target SUDs and increase the reach of effective
treatments.16,18,34,35
Strength and limitations
One strength of this review was the comprehensive database search.
Another important strength was following recommended steps for
converting ICERs to the same currency for the same year to enable
comparisons between studies. Yet, expressing ICERs in the same
currency still does not account for different collection and
valuation of costs between studies. Some limitations are to be
mentioned. Included studies used a variability of methods, such as
varying time horizons, comparators and study perspectives,
hindering comparison of results. For example, next to differences
in costs due to different study perspectives, studies differed with
regard to the inclusion and exclusion of IMI development costs.
Whereas some studies included these costs, in other studies these
costs were considered as sunk costs. In addition, only four studies
included TAU as alternative, which restricts the interpretation as to
whether IMIs are cost-effective compared with standard care.
Another limitation is that conclusions about long-term cost-effect-
iveness of IMIs cannot be made since only 1 out of 11 studies
included a time frame beyond 18 months.
Practical implications and future research
The economic evaluations incorporated in this review comparing an
IMI to TAU mostly demonstrated favourable cost-effectiveness
across varying target populations. IMIs cost less than face-to-face
health care services for SUDs (i.e. counselling by a GP or practice
nurse) and showed no worse clinical outcomes (i.e. abstinence
rates). The lower cost of IMIs, particularly with regard to
investment of therapists’ time, may facilitate the increase in
provision of interventions for alcohol use disorder and smoking
cessation. However, studies lacked evidence for cost-effectiveness
of IMIs when QALYs were included as the outcome of interest. A
possible explanation could be that a time horizon of maximal
12 months was not sufficiently long for the beneficial effects of
IMIs on abstinence to be translated into detectable changes in
quality of life. More specifically, it needs to be taken into account
that owing to the toxicity of tobacco and alcohol their adverse health
effects linger on in former smokers and former drinkers for many
years. Thus, cessation/abstinence does not translate itself immedi-
ately into health gains. For that, randomized controlled trials
including both sustained/prolonged abstinence plus longer follow-
up times are needed. However, this might not be feasible in any case.
Modelling studies could extrapolate trial findings and thus give an
indication about the long-term cost-effectiveness of IMIs for SUDs.
However, to the best of our knowledge, no systematic review on
model-based economic evaluations of IMIs for SUDs has been
conducted so far. In addition, evidence for the cost-effectiveness of
IMIs for SUDs other than alcohol and tobacco use is scarce. There is
accumulating evidence for IMIs for cannabis use.11 However, the
cost-effectiveness of such IMIs has not yet been evaluated.
Conclusion
In conclusion, in the small sample of studies with both outcome data
and economic evaluations, IMIs for SUDs showed a high probability
of being more cost-effective than treatment as usual (e.g. lower costs
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per additional abstinent person). However, incremental cost-utility
analyses based on QALYs gained were less convincing, perhaps
owing to the persistence of adverse health effects of alcohol and
tobacco after (prolonged) cessation. With an increasing pressure
on budgets of health care systems, strategies to disseminate
effective interventions at affordable costs are direly needed. Results
of this review are promising and support the notion that
employment of IMIs might be a cost-effective strategy to scale-up
existing evidence-based treatments for SUDs.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Due to the heterogeneity in types of internet- and mobile-
based interventions, sorts of ‘treatment-as-usual’ and
targeted conditions, no single and general conclusion
about the cost-effectiveness of internet interventions can
be presented in this fragmented research field.
 The economic evaluations included in this systematic review
comparing an internet- and mobile-based intervention to a
control condition mostly demonstrated favourable cost-ef-
fectiveness across varying target conditions.
 Results of this review are promising and support the notion
that employment of internet- and mobile-based interven-
tions might have the potential as cost-effective strategy to
scale-up existing evidence-based treatments for substance
use disorders.
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